Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UCHL1 | P09936 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CXCR2 | P25025 | 4/20 | 0.33 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | CCR6 | P51684 | 1/20 | 0.32 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.32 |
| ▸ | LIPE | Q05469 | 3/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.31 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.31 |
| ▸ | P4HB | P07237 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17429704 | 0.90 | UCHL1 (0.33) | UCHL1ALDH1A1KDM4ECXCR2MAPK10 | |
| SCHEMBL17400118 | 0.83 | LIPG (0.37) | UCHL1ALDH1A1KDM4ECXCR2LIPE | |
| SCHEMBL17385991 | 0.83 | UCHL1 (0.39) | UCHL1ALDH1A1KDM4ECXCR2USP2 | |
| SCHEMBL17429645 | 0.82 | TDP1 (0.35) | UCHL1ALDH1A1KDM4ECXCR2MAPK10 | |
| SCHEMBL19810704 | 0.81 | CCR6 (0.45) | ALDH1A1KDM4EMAPK10USP2CCR6 | |
| SCHEMBL17385776 | 0.77 | UCHL1 (0.38) | UCHL1ALDH1A1KDM4ECXCR2USP2 | |
| SCHEMBL17429652 | 0.77 | UCHL1 (0.33) | UCHL1ALDH1A1KDM4ECXCR2MAPK10 | |
| SCHEMBL17429651 | 0.76 | CYP4A11 (0.38) | UCHL1ALDH1A1KDM4ECXCR2GAA | |
| SCHEMBL17429702 | 0.76 | CXCR2 (0.35) | UCHL1ALDH1A1CXCR2LIPEMTNR1A | |
| SCHEMBL18362455 | 0.75 | CXCR2 (0.39) | UCHL1ALDH1A1KDM4ECXCR2LIPE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9643946-B2 | Tricyclic compound and use thereof | SK CHEMICALS CO., LTD. (KR) | 2017-05-09 | — | — | US | disclosed |
| US-20160009677-A1 | TRICYCLIC COMPOUND AND USE THEREOF | SK CHEMICALS CO., LTD. (KR) | 2016-01-14 | — | — | US | disclosed |
| EP-2963027-A1 | TRICYCLIC COMPOUND AND USE THEREOF | SK Chemicals Co., Ltd. (KR) | 2016-01-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160009677-A1 | TRICYCLIC COMPOUND AND USE THEREOF | GPR65, GPR119, GPR35 | UCHL1 4494/4885ALDH1A1 2066/4885KDM4E 3682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.